-
Dec 05 |
Diagnostics World | Researchers from Simon Fraser University in Burnaby, Canada, and the University of British Columbia in Vancouver, Canada, have discovered a genetic signature in newborn infants that can predict neonatal sepsis before symptoms show. Neonatal sepsis is difficult to diagnose because of the nonspecific clinical signs that are often considered typical behavior issues in newborns, such as difficulty feeding and irritability. Therefore, most infants are not diagnosed until they start developing or have acquired the disease.
More
-
Dec 03 |
Diagnostics World | Most people in the United States have gotten no closer to malaria than the evening news, making the devasting nature of the infection in sub-Saharan Africa hard to fathom. Possibly once or more a day, people are being bitten by pathogen-carrying mosquitoes that cause untold hours of missed work and school and ultimately claim the lives of over half a million people—most of them young children.
More
-
Nov 26 |
Diagnostics World | Alimetry plans to commercialize its wearable gut health monitoring device; PrognomiQ launches in vitro diagnostic; and more.
More
-
Nov 25 |
Diagnostics World | NOWDiagnostics announced that its First To Know Syphilis Test, a key tool in syphilis prevention, is available for purchase nationwide; Veravas announced the results of an analytical verification study of its VeraBIND Tau assay, a next-generation test being co-developed with Phanes Biotech for the detection of Alzheimer’s disease at its earliest, most treatable stages; and more.
More
-
Nov 21 |
Diagnostics World | Illumina announced an expansion of its TruSight Oncology portfolio this week at the annual meeting of the Association of Molecular Pathology (AMP) in Vancouver, British Columbia, with TruSight Oncology 500 v2 planned for global release in mid-2025.
More
-
Nov 19 |
Diagnostics World | A team of researchers from Institute of Science Tokyo, Japan, are using nanowires with machine learning analysis to detect cancer-associated miRNAs in urine. Their research findings were published last month online in Analytical Chemistry.
More
-
Nov 15 |
Diagnostics World | Placental pathology has potential to reveal critical insights into pregnancy complications, yet it remains underutilized in clinical trials. By incorporating placental evaluations into clinical research, doctors could better understand and treat conditions like preeclampsia and preterm birth, which are currently diagnosed based only on clinical signs.
More
-
Nov 13 |
Diagnostics World | Researchers in Israel recently showcased a novel platform that can be used in the future for the early diagnosis of Parkinson’s disease (PD) by quantifying the distribution of alpha-synuclein (α-syn) in skin biopsies. A proof-of-concept study in humans, supported in part by the Michael J. Fox Foundation, suggests the single-molecule-level detection method might enable the disease to be detected up to 20 years before the first motor symptoms appear.
More
-
Nov 12 |
Diagnostics World | Recent years have seen progress toward developing tools that are designed to analyze a human breath sample to detect, diagnose, or monitor various health issues. Some of these efforts have focused on combating deadly infectious diseases, with intentions of creating cost-effective, easy-to-use breathalyzers capable of being deployed in rural, remote, and low-resource settings.
More
-
Nov 07 |
Diagnostics World | A next-generation liquid biopsy approach combining cell-free DNA (cfDNA) “fragmentome” and protein biomarker analyses could aid in the early detection of ovarian cancer, suggests a recent study by researchers in the U.S., The Netherlands, and Denmark. The DELFI-Pro classifier was found to have a high positive predictive value, a key accuracy metric.
More
-
Dec 06 |
Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.
More
-
Dec 03 |
Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.
More
-
Dec 02 |
More
-
Dec 02 |
Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.
More
-
Nov 25 |
Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.
More
-
Nov 22 |
CIRCOR International, Inc., a leading manufacturer and marketer of differentiated technology products and sub-systems, highlights its new BB PEP Series pumps, engineered for high-precision performance in polymer extrusion applications. With a focus on consistent, accurate performance, the BB PEP Series addresses critical demands such as uniformity, durability, and ease of maintenance in the chemical, industrial and life sciences industries.
More
-
Nov 22 |
Industry recognition highlights company’s diverse portfolio mix, flexibility and ease of deployment, and data integration capabilities, driving real-time review and insights
More
-
Nov 21 |
In November 2024, a $60 million fundraising transaction for Series E preferred stock was successfully closed by Beta Bionics, Inc., a trailblazing leader in the creation of cutting-edge diabetes treatment solutions.
More
-
Nov 21 |
With the global fight against the monkeypox epidemic intensifying, Creative Biolabs has risen to the occasion by introducing a comprehensive monkeypox virus vaccine development strategy.
More
-
Nov 21 |
Augurex Life Sciences and Quest Diagnostics have partnered to reintroduce a lab-developed test based on the 14-3-3η (eta) biomarker for rheumatoid arthritis (RA) diagnosis and management in the U.S. Quest will offer the test starting December 2, 2024, through its San Juan Capistrano laboratory, with blood samples collected at over 2,000 patient service centers nationwide. The 14-3-3eta test helps identify RA-specific protein levels, aiding in earlier treatment decisions and improved care for patients with inflammatory diseases.
More
View more articles